788 filings
Page 11 of 40
6-K
wtabxzczz0pkmiwj
6 Apr 20
AETERNAzentaris announces positive Results In Dose-finding pediatric study of Macimorelin
9:30am
6-K
9pd3n02g3xnx1hc6jx
31 Mar 20
Consolidated Financial Statements
12:00am
6-K
6e6bqniqpw6us
26 Mar 20
Current report (foreign)
3:02pm
6-K
rz8xjjxd
12 Mar 20
Aeterna Zentaris Announces Settlement of Previously Disclosed class-action lawsuit
2:38pm
D
l4u2vlaj9no3f884hqmc
2 Mar 20
$4.5M in options / securities to be acquired, sold $4.5M, 3 investors
12:00am
6-K
f45d2w84
28 Feb 20
Current report (foreign)
4:05pm
6-K
4hp05
21 Feb 20
Aeterna Zentaris Announces CLOSING OF $4.5 Million
4:10pm
424B5
4r86y9 0n16ohy
21 Feb 20
Prospectus supplement for primary offering
9:33am
6-K
x5swgsio
21 Feb 20
Current report (foreign)
9:31am
6-K
m55qh5z
20 Feb 20
Aeterna Zentaris Announces $4.5 Million Registered Direct Offering priced at-the-market
6:15am
6-K
qavfi7wchfq
12 Feb 20
AETERNAzentaris to PRESENT at Noble Capital Markets’ 16th Annual Investor Conference
8:57am
6-K
auvm dl7u
28 Jan 20
AETERNAzentaris announces completion of patient recruitment In Dose-finding pediatric study of Macimorelin
12:28pm
6-K
ogbi 17wbylfrj
27 Jan 20
Current report (foreign)
4:34pm
6-K
zydd8u170k v7k
8 Jan 20
Aeterna Zentaris Receives NASDAQ Notification Regarding Minimum Bid Price Requirement
4:01pm
6-K
yt5vk
18 Dec 19
Aeterna Zentaris Announces Publication of GHD Management Guidelines
9:09am
6-K
pyoz24
16 Dec 19
Aeterna Zentaris Announces 2020 Director Changes
9:00am
6-K
dy3xxnk5osktqpsv
8 Nov 19
Aeterna Zentaris Reports Third Quarter 2019 Financial and Operating Results
12:00am
6-K
pe07d 1h14
7 Nov 19
Condensed Interim Consolidated Financial Statements
5:01pm
6-K
gc3xhr 5au0
8 Oct 19
Material Change Report
11:58am